Personalized Best: Toward Improving Care in Ulcerative Colitis.
作者信息
Jampala Nannaya, Jain Animesh, Herfarth Hans H, Long Millie D, Weaver Kimberly N, Barnes Edward L
机构信息
Division of Gastroenterology and Hepatology, University of North Carolina At Chapel Hill, Campus Box #7080, 130 Mason Farm Road, Chapel Hill, NC, 27599-7080, USA.
Multidisciplinary Center for Inflammatory Bowel Diseases, University of North Carolina At Chapel Hill, Chapel Hill, NC, USA.
出版信息
Dig Dis Sci. 2021 Nov;66(11):3736-3739. doi: 10.1007/s10620-021-07221-w. Epub 2021 Aug 31.
Abstract
摘要
相似文献
1
Personalized Best: Toward Improving Care in Ulcerative Colitis.个性化最佳方案：致力于改善溃疡性结肠炎的治疗
Dig Dis Sci. 2021 Nov;66(11):3736-3739. doi: 10.1007/s10620-021-07221-w. Epub 2021 Aug 31.
2
ACG Clinical Guideline: Ulcerative Colitis in Adults.ACG 临床指南：成人溃疡性结肠炎。
Am J Gastroenterol. 2019 Mar;114(3):384-413. doi: 10.14309/ajg.0000000000000152.
3
Advances in Pediatric Inflammatory Bowel Disease.小儿炎症性肠病的进展
Adolesc Med State Art Rev. 2016 Spring;27(1):57-74.
4
Nephrotic syndrome and Moya-moya syndrome in a patient with ulcerative colitis.
Inflamm Bowel Dis. 2012 Apr;18(4):E798-800. doi: 10.1002/ibd.21850. Epub 2011 Oct 10.
5
Celiac disease associated with ulcerative colitis.乳糜泻合并溃疡性结肠炎。
Ter Arkh. 2019 Mar 18;91(2):87-90. doi: 10.26442/00403660.2019.02.000152.
6
[Treatment of steroid-refractory ulcerative colitis with infliximab].英夫利昔单抗治疗激素难治性溃疡性结肠炎
Gastroenterol Hepatol. 2003 Jan;26(1):54-5. doi: 10.1016/s0210-5705(03)70344-6.
7
8
[Long-term adalimumab therapy in ulcerative colitis in clinical practice: result of the Hungarian multicenter prospective study].[临床实践中溃疡性结肠炎的长期阿达木单抗治疗：匈牙利多中心前瞻性研究结果]
Orv Hetil. 2016 May 1;157(18):706-11. doi: 10.1556/650.2016.30429.
9
Regain of Response to Adalimumab in a Steroid-Dependent Pediatric Patient With Ulcerative Colitis After Undergoing Selective Granulocyte and Monocyte Apheresis.一名依赖类固醇的溃疡性结肠炎儿科患者在接受选择性粒细胞和单核细胞单采术后对阿达木单抗恢复反应
Inflamm Bowel Dis. 2019 Jun 18;25(7):e82-e83. doi: 10.1093/ibd/izy404.
10
Positioning Therapy for Ulcerative Colitis.溃疡性结肠炎的定位治疗
Curr Gastroenterol Rep. 2015 Aug;17(8):29. doi: 10.1007/s11894-015-0454-0.
引用本文的文献
1
An Overview of the GI Fellowship Interview: Part II-Tips for Selection Committees and Interviewers.胃肠病学 fellowship 面试概述：第二部分——给选拔委员会和面试官的建议。
Dig Dis Sci. 2022 May;67(5):1712-1717. doi: 10.1007/s10620-022-07409-8. Epub 2022 Feb 5.
本文引用的文献
1
Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-What, Why, and How.ECCO 第七次科学研讨会成果：炎症性肠病精准医学——是什么、为什么以及如何实现。
J Crohns Colitis. 2021 Sep 25;15(9):1410-1430. doi: 10.1093/ecco-jcc/jjab051.
2
Immunomodulator and Biologic Combination Therapy in IBD: The Debate That Just Won't Go Away?
J Crohns Colitis. 2020 Oct 5;14(10):1343-1344. doi: 10.1093/ecco-jcc/jjaa070.
3
Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring?优化炎症性肠病的生物治疗：治疗药物监测有多重要？
Nat Rev Gastroenterol Hepatol. 2020 Nov;17(11):702-710. doi: 10.1038/s41575-020-0352-2. Epub 2020 Sep 2.
4
HLADQA1*05 genotype predicts anti-drug antibody formation and loss of response during infliximab therapy for inflammatory bowel disease.HLADQA1*05 基因型可预测英夫利昔单抗治疗炎症性肠病时抗药物抗体的形成和应答丧失。
Aliment Pharmacol Ther. 2020 Feb;51(3):356-363. doi: 10.1111/apt.15563. Epub 2019 Oct 25.
5
Decreasing Colectomy Rate for Ulcerative Colitis in the United States Between 2007 and 2016: A Time Trend Analysis.2007 年至 2016 年期间美国溃疡性结肠炎结肠切除术率的下降：时间趋势分析。
Inflamm Bowel Dis. 2020 Jul 17;26(8):1225-1231. doi: 10.1093/ibd/izz247.
6
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.HLA-DQA1*05 携带与克罗恩病患者对英夫利昔单抗和阿达木单抗的药物抗体发展相关。
Gastroenterology. 2020 Jan;158(1):189-199. doi: 10.1053/j.gastro.2019.09.041. Epub 2019 Oct 7.
7
A Population-Based Study of Combination vs Monotherapy of Anti-TNF in Persons With IBD.基于人群的研究：在 IBD 患者中，联合使用抗 TNF 与单药治疗的比较。
Inflamm Bowel Dis. 2020 Jan 1;26(1):150-157. doi: 10.1093/ibd/izz148.
8
Challenges in IBD Research: Precision Medicine.炎症性肠病研究的挑战：精准医学。
Inflamm Bowel Dis. 2019 May 16;25(Suppl 2):S31-S39. doi: 10.1093/ibd/izz078.
9
Adalimumab Monotherapy and a Combination with Azathioprine for Crohn's Disease: A Prospective, Randomized Trial.阿达木单抗单药治疗及与硫唑嘌呤联合治疗克罗恩病：一项前瞻性随机试验
J Crohns Colitis. 2016 Nov;10(11):1259-1266. doi: 10.1093/ecco-jcc/jjw152. Epub 2016 Aug 26.
10
A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia.NUDT15基因中的一种常见错义变异会使人易患硫嘌呤诱导的白细胞减少症。
Nat Genet. 2014 Sep;46(9):1017-20. doi: 10.1038/ng.3060. Epub 2014 Aug 10.
Zotero 插件